Article Information
History
- April 7, 2024.
Article Versions
- Version 1 (April 5, 2024 - 00:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Vanaja Kumar1,4,*,
- Balagurunathan Ramasamy2,
- Mukesh Doble3,5,$,
- Radhakrishnan Manikkam4,
- Luke Elizabeth Hanna1,
- Gandarvakottai Senthilkumar Arumugam3,7,
- Kannan Damodharan3,
- Suresh Ganesan3,
- Azger Dusthakeer1,
- Precilla Lucia1,
- Shainaba A Saadhali1,
- Shanthi John2,
- Poongothai Eswaran2,
- Selvakumar Nagamiah1,
- Jaleel UCA6,
- Rakhila M6,
- Ayisha Safeeda6 and
- Sathish S6
- 1National Institute for Research in Tuberculosis, Chennai – 600031, Tamilnadu, India
- 2Department of Microbiology, Periyar University, Salem – 636011, Tamilnadu, India
- 3Department of Biotechnology, Indian Institute of Technology, Madras – 600036, Tamilnadu, India
- 4Centre for Drug Discovery and Development, Sathyabama Institute of Science and Technology (Deemed to be University), Chennai – 600119, Tamilnadu. India
- 5Saveetha Dental College and Hospitals, 62, Poonamallee High Rd, Chennai, 600077, India
- 6Open Source Pharma Foundation-National Institute of Advanced Studies Drug Discovery Lab, NIAS, IISc Campus, Bangalore, Karnataka, India
- 7SSS International Drug Discovery & Development Research Private Limited, Innovation & Entrepreneurship, Sudha & Shankar innovation hub, IIT Madras, Chennai-600036, India
- ↵*Corresponding Author:
Dr. Vanaja Kumar, Former Scientist G & Head, Department of Bacteriology, National Institute for Research in Tuberculosis, Chennai – 600 031. Tamil Nadu. India, Email: vanaja_kumar51{at}yahoo.co.in
Posted April 07, 2024.
Discovery of a novel antibiotic, Transitmycin, from Streptomyces sp unveils highly efficient activities against tuberculosis and human immunodeficiency virus
